4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-20-065134
Director sold 30,000 shares at an average $90.05 ($2,701,582)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schenkein David P Director | 2020-12-21 | Sale | −25,000 | $90.06 | $2,251,555 | 0 | D |
| Schenkein David P Director | 2020-12-21 | Sale | −5,000 | $90.01 | $450,027 | 26,232 | I |
| Open-market sales · 30,000 sh · avg $90.05 · $2,701,582 | |||||||
Loading xslF345X03/doc4.xml…